StockData
ImmuCell Corp logo

ImmuCell Corp (ICCC) stock

ICCCNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/303% above fair value
$11.42+0.67 (+6.23%)

Close on Nov 16, 2026Market cap $103.72MP/E 142.8Yield –

ImmuCell profit margin

Profit margin (net margin) is net income as a percentage of revenue.

ImmuCell's profit margin for the twelve months ending Jun 30, 2026 was 2.6%. For fiscal 2025 it was -3.8%, against -8.1% the year before. The highest annual figure on record is 11.9% in fiscal 2015.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-3.8%+4.4
FY2024Dec 31, 2024-8.1%+24.9
FY2023Dec 31, 2023-33.1%−19.6
FY2022Dec 31, 2022-13.4%−13.0
FY2021Dec 31, 2021-0.4%+6.3
FY2020Dec 31, 2020-6.7%+2.8
FY2019Dec 31, 2019-9.4%+11.7
FY2018Dec 31, 2018-21.1%−19.5
FY2017Dec 31, 2017-1.6%−6.9
FY2016Dec 31, 20165.3%−6.5
FY2015Dec 31, 201511.9%+14.1
FY2014Dec 31, 2014-2.2%−4.2
FY2013Dec 31, 20132.0%+0.3
FY2012Dec 31, 20121.7%+9.7
FY2011Dec 31, 2011-8.0%+0.8
FY2010Dec 31, 2010-8.8%−4.0
FY2009Dec 31, 2009-4.8%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202625.5%+17.7
Q1 FY2026Mar 31, 202618.7%+0.8
Q4 FY2025Dec 31, 2025-37.4%−44.0
Q3 FY2025Sep 30, 2025-2.5%+9.1
Q2 FY2025Jun 30, 20257.8%+35.8
Q1 FY2025Mar 31, 202517.9%+24.0
Q4 FY2024Dec 31, 20246.6%+24.1
Q3 FY2024Sep 30, 2024-11.7%+27.4
Q2 FY2024Jun 30, 2024-28.0%+39.2
Q1 FY2024Mar 31, 2024-6.0%+36.6
Q3 FY2023Sep 30, 2023-17.4%−3.8
Q2 FY2023Jun 30, 2023-39.1%−21.3
Q1 FY2023Mar 31, 2023-67.2%−75.7
Q4 FY2022Dec 31, 2022-42.6%−44.0
Q3 FY2022Sep 30, 2022-13.7%−16.5
Q2 FY2022Jun 30, 2022-17.7%−20.8
Q1 FY2022Mar 31, 20228.6%+19.3
Q4 FY2021Dec 31, 20211.4%−3.7
Q3 FY2021Sep 30, 20212.9%+11.5
Q2 FY2021Jun 30, 20213.1%+28.9
Q1 FY2021Mar 31, 2021-10.7%−8.3
Q4 FY2020Dec 31, 20205.0%+13.6
Q3 FY2020Sep 30, 2020-8.7%+8.2
Q2 FY2020Jun 30, 2020-25.8%−2.7
Q1 FY2020Mar 31, 2020-2.5%−5.8
Q4 FY2019Dec 31, 2019-8.5%+27.3
Q3 FY2019Sep 30, 2019-16.9%−5.3
Q2 FY2019Jun 30, 2019-23.1%+3.3
Q1 FY2019Mar 31, 20193.3%+11.0
Q4 FY2018Dec 31, 2018-35.8%−29.6
Q3 FY2018Sep 30, 2018-11.6%+5.3
Q2 FY2018Jun 30, 2018-26.5%−14.0
Q1 FY2018Mar 31, 2018-7.7%−24.2
Q4 FY2017Dec 31, 2017-6.2%−7.6
Q3 FY2017Sep 30, 2017-16.9%−18.7
Q2 FY2017Jun 30, 2017-12.5%–
Q1 FY2017Mar 31, 201716.5%–
Q4 FY2016Dec 31, 20161.4%–
Q3 FY2016Sep 30, 20161.8%–

More ImmuCell figures

See a number that looks wrong?